Skip to content

Combined Prospective and Retrospective Post-Market Follow Up of the 'BPK-S Integration' UC as Primary Implant in the Variant CoCr

Combined Prospective / Retrospective, Open, Non-randomized, Non-interventional Post Market Clinical Follow-Up of the BPK-S Integration System (Co28Cr6Mo) Used for Primary Total Knee Replacement

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03406637
Enrollment
62
Registered
2018-01-23
Start date
2018-10-17
Completion date
2020-03-02
Last updated
2020-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Joint Instability, Osteoarthritis, Knee

Brief summary

Patients who received a total knee endoprosthesis BPK-S Integration between 2011 and 2013 will be invited to participate in this PMCF study provided sufficient source data documentation is available regarding preoperative, intraoperative and early postoperative follow-up assessments. Only patients providing written informed consent prior to any study data collection can take part in the study. Preoperative, intraoperative and early postoperative data (3 months, 1 year and 2 years after implantation) will be collected retrospectively. Additional long-term follow-up of one visit (year 7 after implantation) will be documented prospectively. Only parameters assessed in clinical standard care for follow-up (implant control) visits will be collected for this PMCF study. Radiological assessment of the implanted prosthesis will only be conducted if medically indicated according to the investigator. No additional study related assessment will be performed. Only anonymized data will be used in this observational study to protect patient privacy. No personally identifiable information will be collected.

Interventions

primary total knee endoprosthesis

Sponsors

P.R.I.S.M.A.-CRO
CollaboratorUNKNOWN
Peter Brehm GmbH
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Patients that received a total primary knee endoprosthesis BPK-S Integration (Co28Cr6Mo) between 2011 and 2013 * Patients that agree to participate and give written informed consent to the anonymized retrospective and prospective data collection within the study

Exclusion criteria

No study specific

Design outcomes

Primary

MeasureTime frameDescription
Patient relevant benefit after 5 years7 yearsimprovement of KSS-Score by at least one category as compared to preoperative basic assessment

Secondary

MeasureTime frameDescription
Safety parameters7 yearsIncidents that require reporting to the competent authority and complications during and after surgery as documented in source documentation
Patient relevant benefit as measured by American Knee Society Score1 yearimprovement of KSS-Score as compared to preoperative basic assessment
Implant Loosening Number7 yearsNumber of implant loosening due to quality issues with the implant
Implant Loosening Reason7 yearsReason for implant loosening due to quality issues with the implant
Revision Number7 yearsNumber of revisions, if required
Revision Reason7 yearsReason for revision, if required
Surgery ParametersDay 0 = day of surgeryEvaluation of surgery time as documented in the surgical report

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026